We have launched Asper Nephrology testing portfolio to expand our testing menu and cover more clinical areas.
We have integrated CNV detection tool into our everyday workflow. CNV analysis is now available as a new testing option for all NGS panels and WES.
Asper Neurogenetics testing portfolio has been updated with Brunner syndrome test, and CNV analysis for all gene panels.
We now offer an NGS panel for Hereditary Hemorrhagic Telangiectasia. Additionally, Noonan Syndrome test has been upgraded to Noonan Spectrum Disorders/Rasopathies test.